dostarlimab
gsk
['radio', 'rectal', 'dostarlimab']
andrea cercek lba at #asco22 14 of 14 (100%) mmrd rectal cancers had complete clinical response with dostarlimab immunotherapy. moving rapidly away from chemotherapy, radiotherapy and potentially even surgery in these tumours. 
Medical Oncologist and Clinician Scientist working on GI Cancer Genomics/Cancer Evolution, Immunotherapies and Biomarkers